The Scientist

» neurodegenerative diseases and immunology

Most Recent

image: Opinion: Canine Models for Alzheimer’s

Opinion: Canine Models for Alzheimer’s

By | March 1, 2017

For research on drugs to treat neurodegenerative diseases, dogs offer a better predictor of clinical outcomes. 

7 Comments

image: Unique Antibodies Open Path Toward New HIV Vaccines

Unique Antibodies Open Path Toward New HIV Vaccines

By | January 27, 2017

A family of broadly neutralizing antibodies from a chronically infected donor provides a schematic for designing vaccines and treatments that target multiple strains of the virus.

0 Comments

image: FDA Approves First Treatment for Spinal Muscular Atrophy

FDA Approves First Treatment for Spinal Muscular Atrophy

By | December 28, 2016

The oligonucleotide therapeutic will soon be available in the U.S.

0 Comments

image: Mouse Immunology Paper Retracted

Mouse Immunology Paper Retracted

By | December 16, 2016

A finding of misconduct spurs the retraction of a Science paper claiming to have identified a protein in mice that boosted immunity to both viruses and cancer.

1 Comment

image: Naive T Cells Find Homes in Lymphoid Tissue

Naive T Cells Find Homes in Lymphoid Tissue

By | December 2, 2016

The human lymph nodes and spleen maintain unique, compartmentalized sets of naive T cells well into old age.

0 Comments

image: Gut Microbes Linked to Neurodegenerative Disease

Gut Microbes Linked to Neurodegenerative Disease

By | December 1, 2016

Bacteria in the intestine influence motor dysfunction and neuroinflammation in a mouse model of Parkinson’s disease.

3 Comments

image: Low Social Status May Weaken Immune System in Monkeys

Low Social Status May Weaken Immune System in Monkeys

By | November 29, 2016

Life at the bottom of the pecking order ramps up inflammation, according to new research, an effect that appears to be reversible.

0 Comments

image: More than 40 New Papers on Epigenetics Published

More than 40 New Papers on Epigenetics Published

By | November 22, 2016

The International Human Epigenome Consortium presents a series of studies on how epigenetics influences immunity, cell lineage determination, and differentiation.

0 Comments

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

image: Contributors

Contributors

By | November 1, 2016

Meet some of the people featured in the November 2016 issue of The Scientist.

0 Comments

Popular Now

  1. Unstructured Proteins Help Tardigrades Survive Desiccation
  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Inflammation Drives Gut Bacteria Evolution
Business Birmingham